First Time Loading...

LAVA Therapeutics NV
NASDAQ:LVTX

Watchlist Manager
LAVA Therapeutics NV Logo
LAVA Therapeutics NV
NASDAQ:LVTX
Watchlist
Price: 3.03 USD -2.26% Market Closed
Updated: May 4, 2024

LAVA Therapeutics NV
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

LAVA Therapeutics NV
Revenue Peer Comparison

Comparables:
PHARM
QURE
ARGX
MRUS
N
NAMS

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
LAVA Therapeutics NV
NASDAQ:LVTX
Revenue
$6.8m
CAGR 3-Years
25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pharming Group NV
AEX:PHARM
Revenue
$245.3m
CAGR 3-Years
5%
CAGR 5-Years
11%
CAGR 10-Years
43%
Uniqure NV
NASDAQ:QURE
Revenue
$15.8m
CAGR 3-Years
-25%
CAGR 5-Years
7%
CAGR 10-Years
14%
argenx SE
XBRU:ARGX
Revenue
$1.2B
CAGR 3-Years
210%
CAGR 5-Years
121%
CAGR 10-Years
N/A
Merus NV
NASDAQ:MRUS
Revenue
$43.9m
CAGR 3-Years
14%
CAGR 5-Years
3%
CAGR 10-Years
N/A
N
NewAmsterdam Pharma Company NV
NASDAQ:NAMS
Revenue
€97.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is LAVA Therapeutics NV's Revenue?
Revenue
6.8m USD

Based on the financial report for Dec 31, 2023, LAVA Therapeutics NV's Revenue amounts to 6.8m USD.

What is LAVA Therapeutics NV's Revenue growth rate?
Revenue CAGR 3Y
25%

Over the last year, the Revenue growth was -65%. The average annual Revenue growth rates for LAVA Therapeutics NV have been 25% over the past three years .